Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1145 of 6351
-
A gentle touch: can tailored care rewire the brains of tiny preterm babies?
Knowledge-focused CompletedThe purpose of the study is to learn more about the development of small for gestational age (SGA) preterm infants and whether focusing on the infant's behavior has a positive effect on outcome. The study hypotheses state: 1) High risk severely SGA preterm infants will profit fro…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can we unlock the secrets of hereditary cancer genes?
Knowledge-focused OngoingThe goal of this study is to help us learn more about the roles of genes in cancers that run in families. Sometimes, we are born with genes that are changed or altered. Gene changes are called mutations. Mutations may be passed down from parent to child. Some mutations cause a hi…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Baby tamoxifen shows promise in preventing breast cancer recurrence
Prevention CompletedLow-dose tamoxifen (5 mg/day for three years, BabyTam) has emerged as a safer and effective alternative to the standard regimen (20 mg/day), reducing breast cancer recurrence with fewer adverse events. The TAM-01 phase III trial demonstrated a 42% reduction in breast cancer event…
Sponsor: Ente Ospedaliero Ospedali Galliera • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Can MRI outshine mammograms in finding breast cancer?
Diagnosis Recruiting nowTo compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Sponsor: Stanford University • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Can a family registry crack the code of inherited pancreatic cancer?
Knowledge-focused Recruiting nowThe NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The investigators are particularly interested in finding the genes that cause pancreatic cancer t…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can men with spinal cord injury father children? a new study explores fertility options
Knowledge-focused Recruiting nowFollowing spinal cord injury, most men are infertile and require medical assistance to father children. The conditions that contribute to their infertility are erectile dysfunction, ejaculatory dysfunction, and semen abnormalities. The Miami Project Male Fertility Program is a re…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Bionic hand control gives new grip to paralyzed patients
Disease control OngoingThe purpose of this study is to evaluate the effectiveness of an implanted stimulator and sensor for providing hand and arm function for individuals with cervical level spinal cord injury.
Sponsor: MetroHealth Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could common food additives be friend or foe? a massive study investigates
Knowledge-focused CompletedNitrate, nitrite, and phosphate (NO3, NO2, P) are at all age stages ubiquitous in our everyday foods, including naturally occurring and as food additives, and in our drinking water. These compounds are essential in maintaining human well-being and health, but they have also been …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New hope for rare lung disease: investigational drug now available through expanded access
Disease control Expanded accessAutoimmune pulmonary alveolar proteinosis (aPAP) is a rare disorder in which a material called surfactant builds up in the lungs and makes it hard to breathe. In addition to shortness of breath, people with aPAP can experience persistent cough, overwhelming fatigue, unintentional…
Sponsor: Savara Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New immunotherapy option for High-Risk pancreatic cancer patients
Disease control Expanded access (ended)This is an open-label expanded access protocol (EAP) of ELI-002 7P immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide \[Amph-CpG-7909\] plus a mixture of lipid-conjugated peptide-based antigens \[Amph-Peptides 7P\]) as adjuvant treatment in patients with KRAS/NR…
Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Last-Resort leukemia treatment made available through expanded access program
Disease control Expanded accessThe purpose of this program is to provide access to obe-cel treatment for adult patients with ALL who have undergone leukapheresis and had obe-cel manufactured from their blood cells but the product is deemed OOS (does not meet the specifications to be used commercially). The tar…
Sponsor: Autolus Limited • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Free daily shot offers hope for hemophilia patients
Disease control Expanded accessThe compassionate use programme will give participants concizumab for free, even though it is not yet approved by health authorities. This is because participants need this medicine to treat their haemophilia properly. The programme will check that participants are safe and that …
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a Two-Drug combo outsmart childhood cancers that resist treatment?
Disease control CompletedLong term survival can now be achieved in 75% of cases of pediatric cancers. However, some types of tumors (ie CNS tumors) or advanced stages (metastatic sarcomas/neuroblastomas) cannot be cured by any treatment. Thus, evaluation of new drugs or combinations are strongly needed. …
Phase 1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Last-resort drug offered to kids with deadly cholesterol condition
Disease control ApprovedProvide compassionate use of evinacumab
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Rare disease drug now available through expanded access
Disease control Expanded accessThis Expanded Access Record for doxecitine and doxribtimine includes the following managed access programs and status: * TK0113: Available * TK0115: No longer Available
Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug option opens for Hard-to-Treat cancers
Disease control Expanded accessAVM Biotechnology, Inc., provides immunomodulatory AVM0703 to solid tumor and blood cancer patients upon request by a US licensed MD or DO. As of July 2024, 37 patients have been treated through this FDA-EAP including patients diagnosed with relapsed or recurring glioblastoma, in…
Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Fish oil treatment offers hope for babies with liver damage from IV nutrition
Disease control ApprovedThis is an expanded access protocol for use of intravenous fish oil infusion, Omegaven, in infants and children with parenteral nutrition associated liver disease (PNALD) to decrease elevated liver enzymes and direct bilirubin. This study aims to describe the response of PNALD a…
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for rare blood disease: expanded access to combo therapy
Disease control Expanded access (ended)This program is designed to provide access to pozelimab and cemdisiran and document the long-term safety of pozelimab and cemdisiran combination therapy in patients with paroxysmal nocturnal hemoglobinuria (PNH). PNH is a rare immune disease that causes red blood cells in your bo…
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for hepatitis delta: expanded access to bulevirtide
Disease control ApprovedThe goal of this study is to provide access to bulevirtide (BLV (GS-4438), Hepcludex®) to eligible participants with chronic hepatitis delta virus infection (CHD).
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Stem cell hope for rare brain disease: new expanded access trial opens
Disease control Expanded accessThis expanded access protocol is part of IND 32226 to evaluate efficacy and safety of multiple intravenous administrations of allogeneic HB-adMSCs for the treatment of Multiple System Atrophy for up to 7 adult patients who pass pre-screening and a completed screening. The subject…
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC